US0441861046 - Common Stock - After market: 96.68 0 (0%)
NYSE:ASH (3/20/2023, 8:04:00 PM)+1.68 (+1.77%)
|Earnings (Last)||01-31 2023-01-31/amc||Earnings (Next)||04-24 2023-04-24/amc|
|Ins Owners||0.26%||Inst Owners||91.83%|
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company is headquartered in Wilmington, Delaware and currently employs 3,900 full-time employees. The company serves customers in a range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceuticals. Its segments include life sciences, personal care, specialty additives, and intermediates. The life sciences segment includes pharmaceuticals, nutraceuticals and nutrition, and diagnostic films and agricultural chemicals. The personal care segment skin and sun care, hair care, oral care, home care, and others. The specialty additives segment includes coatings, construction, and energy. The intermediates segment produces and supplies butanediol (BDO), Tetrahydrofuran (THF), n-methyl-pyrrolidone (NMP) and gamma-butyrolactone (GBL, BLO) in addition to other downstream products. Its products include acrylates, aquaflow, biofunctionals, cellulosics, cyclodextrins, encapsulates, emollient esters, emulsifiers, and others.
8145 Blazer Drive
Wilmington DELAWARE 19808
CEO: Guillermo Novo
Company actions drive gender parity
Ashland (ASH) on Thursday was downgraded to Underweight from an investment rating of Neutral by analysts at JPMorgan
Ashland press release (ASH): Q1 Non-GAAP EPS of $0.97 beats by $0.03.Revenue of $525M (+2.5% Y/Y) beats by $8.42M.Ashland continues to expect sales in the range of $2.5 billion to...
Sales of $525 million, up three percent from the prior-year quarterNet income (including discontinued operations) of $40 million, or $0.73 per diluted...
Here you can normally see the latest stock twits on ASH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.